198 related articles for article (PubMed ID: 36866403)
21. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center.
Kim DH; Murovic JA; Tiel RL; Moes G; Kline DG
J Neurosurg; 2005 Feb; 102(2):246-55. PubMed ID: 15739552
[TBL] [Abstract][Full Text] [Related]
22. DNA cytofluorometric analysis of benign and malignant nerve sheath tumors.
Tsuji Y; Kusuzaki K; Kuzuhara A; Murata H; Takeshita H; Hirata M; Hashiguchi S; Hirasawa Y; Ashihara T
Anticancer Res; 2000; 20(6C):4691-6. PubMed ID: 11205202
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Ristow I; Madesta F; Well L; Shenas F; Wright F; Molwitz I; Farschtschi S; Bannas P; Adam G; Mautner VF; Werner R; Salamon J
Neuro Oncol; 2022 Oct; 24(10):1790-1798. PubMed ID: 35426432
[TBL] [Abstract][Full Text] [Related]
24. Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2.
Halliday AL; Sobel RA; Martuza RL
J Neurosurg; 1991 Feb; 74(2):248-53. PubMed ID: 1846409
[TBL] [Abstract][Full Text] [Related]
25. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.
Wasa J; Nishida Y; Tsukushi S; Shido Y; Sugiura H; Nakashima H; Ishiguro N
AJR Am J Roentgenol; 2010 Jun; 194(6):1568-74. PubMed ID: 20489098
[TBL] [Abstract][Full Text] [Related]
26. Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
Holtkamp N; Mautner VF; Friedrich RE; Harder A; Hartmann C; Theallier-Janko A; Hoffmann KT; von Deimling A
Acta Neuropathol; 2004 Feb; 107(2):159-68. PubMed ID: 14673600
[TBL] [Abstract][Full Text] [Related]
27. Malignant peripheral nerve sheath tumor in children: A clinicopathologic and molecular study with parallels to the adult counterpart.
Agaram NP; Wexler LH; Chi P; Antonescu CR
Genes Chromosomes Cancer; 2023 Mar; 62(3):131-138. PubMed ID: 36414547
[TBL] [Abstract][Full Text] [Related]
28. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
[TBL] [Abstract][Full Text] [Related]
29. Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital.
Guha D; Davidson B; Nadi M; Alotaibi NM; Fehlings MG; Gentili F; Valiante TA; Tator CH; Tymianski M; Guha A; Zadeh G
J Neurosurg; 2018 Apr; 128(4):1226-1234. PubMed ID: 28686119
[TBL] [Abstract][Full Text] [Related]
30. Peripheral nerve sheath tumors arising in salivary glands: A clinicopathologic study.
Guraya SS; Prayson RA
Ann Diagn Pathol; 2016 Aug; 23():38-42. PubMed ID: 27402223
[TBL] [Abstract][Full Text] [Related]
31. A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(5):5113-20. PubMed ID: 26191206
[TBL] [Abstract][Full Text] [Related]
32. cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.
Karube K; Nabeshima K; Ishiguro M; Harada M; Iwasaki H
J Clin Pathol; 2006 Feb; 59(2):160-5. PubMed ID: 16443732
[TBL] [Abstract][Full Text] [Related]
33. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
[TBL] [Abstract][Full Text] [Related]
34. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
Kazmi SJ; Byer SJ; Eckert JM; Turk AN; Huijbregts RP; Brossier NM; Grizzle WE; Mikhail FM; Roth KA; Carroll SL
Am J Pathol; 2013 Mar; 182(3):646-67. PubMed ID: 23321323
[TBL] [Abstract][Full Text] [Related]
35. MRI features of benign peripheral nerve sheath tumors: how do sporadic and syndromic tumors differ?
Debs P; Luna R; Fayad LM; Ahlawat S
Skeletal Radiol; 2024 Apr; 53(4):709-723. PubMed ID: 37845504
[TBL] [Abstract][Full Text] [Related]
36. DNA ploidy and chromosome (FISH) pattern analysis of peripheral nerve sheath tumors.
Hruska A; Bollmann R; Kovács RB; Bollmann M; Bodó M; Sápi Z
Cell Oncol; 2004; 26(5-6):335-45. PubMed ID: 15623944
[TBL] [Abstract][Full Text] [Related]
37. [Pathologic characteristics of the most frequent peripheral nerve tumors].
Coulon A; Milin S; Laban E; Debiais C; Jamet C; Goujon JM
Neurochirurgie; 2009 Oct; 55(4-5):454-8. PubMed ID: 19744677
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Significance of Ki67 Staining Pattern in Benign Peripheral Nerve Sheath Tumors: An Additional Diagnostic Tool.
Doğukan FM; Erdem ZB
Int J Surg Pathol; 2023 Oct; 31(7):1225-1231. PubMed ID: 36475929
[No Abstract] [Full Text] [Related]
39. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
Benz MR; Czernin J; Dry SM; Tap WD; Allen-Auerbach MS; Elashoff D; Phelps ME; Weber WA; Eilber FC
Cancer; 2010 Jan; 116(2):451-8. PubMed ID: 19924789
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
